Open original FDA record ↗Recall record
- FDA identifier
- Z-1070-2025
- Company in FDA record
- Spectranetics Corporation
- FDA classification date
- Feb 14, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Use of Tack Endovascular system, designed to treat acute dissections of inner wall or lining of an artery by tacking damaged tissue to inner luminal surface, could result in problems with deployment and stability of device in vessel after deployment, which may cause failure to resolve dissection, migration of implant, bailout stenting, reintervention, unintended removal of tack devices, and ischemia.
Source facts
- Action
- On 1/10/2025, Philips mailed recall notices to customers informing them of the following: Firm will no longer distributed the device. Check your product inventory and quarantine any affected devices to prevent use. Do not open or use any products that have been identified within your inventory. Circulate this notice to all users of the device, or to any organization where the affected product may have been transferred, so they are aware of the product Recall. Complete and return the response form via email to igtdc.r@philips.com
- Initiated
- 2025-01-10
- Root cause
- Device Design
- Distribution
- Distribution US nationwide and countries of: NL, DE, NL, AU, IT, CH, GB, and AT
- Recall number
- Z-1070-2025
- Recall status
- Open, Classified
- CDRH record ID
- 211997
- FDA classified
- 2025-02-14
- Recall event number
- 96097